Video

Testing for Biomarkers in Multiple Myeloma

Author(s):

Shaji Kumar, MDJonathan L. Kaufman, MD

Two experts review strategies and barriers to overcome for biomarker testing in patients with multiple myeloma.

Related Videos
C. Ola Landgren, MD, PhD
A panel of 3 experts on breast cancer
A panel of 3 experts on breast cancer
Muhamed Baljevic, MD, FACP
Muhamed Baljevic, MD
Video 2 - "Navigating Glioblastoma Imaging: The Patient Journey from Diagnosis to Treatment "
Video 1 - "Neuroimaging of Glioblastoma"
Video 11 - "Pioneering Breakthroughs in HCC Treatment"
Related Content
OncLive On Air
May 30th 2024

Revisit Every OncLive On Air Episode From May 2024

Stephen Liu, MD; Sara A. Hurvitz, MD, FACP; S. Vincent Rajkumar, MD; Sumanta Kumar Pal, MD, FASCO; Shubham Pant, MD, MBBS
May 23rd 2024

Oncology Experts Preview Top Abstracts From the 2024 ASCO Annual Meeting

FDA
May 27th 2024

FDA Grants Priority Review to Isatuximab Combo for Newly Diagnosed, Transplant-Ineligible Myeloma

Paul G. Richardson, MD
October 2nd 2023

Richardson Reviews Findings and Future Directions With Mezigdomide Plus Dexamethasone in R/R Myeloma

James Ignatz-Hoover, MD, PhD
May 24th 2024

Weighing the Benefits and Limitations of CAR T-Cell Therapy and Bispecific Antibodies in Multiple Myeloma

FDA
May 14th 2024

OncLive’s April Roundup of Key FDA Decisions in Oncology